Home
Neuland Laboratories Ltd Share Price History
Neuland Laboratories Ltd
NSE : 21 Mar, 2025
11792.95111.4 (1.0%)
Prev Close
11681.5
Open Price
11680.0
Bid Price (QTY)
-
Offer Price (QTY)
-
Volume
21516
Today's High / Low
11925.2 / 11560.0
52 WK High / Low
18100.0 / 5540.1
Market Price of Neuland Laboratories Ltd
1M
1Y
3Y
5Y
Monitoring Neuland Laboratories Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.
History Market Price
| Date | Price | Open | High | Low |
|---|
Returns Comparison
1W
1M
3M
6M
1Y
3Y
5Y
10Y
Growth Parameters
| Parameter |  2017 |
|---|---|
| Sales (Cr.) | NaN |
| Sales YoY Gr. | - |
| Adj EPS | 52.33 |
| YoY Gr. | - |
| Net Profit (Cr.) | 47 |
| BVPS | 608.36 |
Key Financial Parameters
| Parameter | 2015 |
|---|---|
| Return on Capital Emp. % | 15.35 |
| Op. Profit Mgn % | 14.15 |
| Net Profit Mgn % | 3.34 |
| Debt to Equity % | 1.33 |
Latest Shareholding
Promoters Holdings Over Time
About Neuland Laboratories Ltd
- Incorporated on January 7, 1984, Neuland Laboratories Limited (NLL) is promoted by Davuluri Sucheth Rao.
- The Company is engaged in manufacturing and selling of bulk drugs such as salbutamol sulphate, terbutaline sulphate, labetalol hydrochloride and ciprofloxacin.
- Neuland Drugs & Pharmaceuticals Pvt.
- Ltd., a company set up by the same promoters to manufacture bulk drugs was merged with the Company effective from April, 1992.
- NLL manufactures bulk drugs. The Company came out with its initial public offering in Apr.'94 at a premium of Rs 35 aggregating Rs 5.69 cr, to part-finance the capacity expansion to manufacture bulk drugs and to diversify its product-mix.
Popular Search
FAQs for Neuland Laboratories Ltd Share Price History
What are the key events that typically impact Neuland Laboratories Ltd's share price history?
Key events that impact Neuland Laboratories Ltd’s share price history include quarterly earnings releases, product launches, leadership changes, economic policies, and geopolitical developments.
How do stock splits affect Neuland Laboratories Ltd's share price history?
Stock splits reduce the nominal price of Neuland Laboratories Ltd's shares by increasing the number of outstanding shares, which typically makes the stock more accessible to a broader range of investors. Although the total market value of the company remains unchanged after the split, the split can affect investor perception and liquidity, potentially influencing the share price in the longer term.
How do dividends impact the share price history of Neuland Laboratories Ltd?
Dividends can influence Neuland Laboratories Ltd's share price history by typically causing a temporary dip on the ex-dividend date, as the stock price often adjusts to reflect the dividend payout. Over time, the impact of dividends on the share price may be offset by the company's overall financial performance and market conditions.
How do corporate announcements affect Neuland Laboratories Ltd’s share price history?
Corporate announcements such as mergers, acquisitions, or strategic shifts can lead to significant price changes. Any optimistic development news on Neuland Laboratories Ltd generally boosts the company’s share price, whereas negative news can lead to a decline in share price.
How can I use technical analysis to understand Neuland Laboratories Ltd’s share price history?
To understand Neuland Laboratories Ltd’s share price history using technical analysis, examine charts for patterns such as trends, support, and resistance levels, and apply indicators like moving averages or Relative Strength Index (RSI) to gauge potential future movements. Analyze historical data to identify recurring trends and signals that might suggest how the share price could behave under similar conditions.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
